Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Rajat Bannerji came to Rutgers Cancer Institute of New Jersey in 2012 following six years of conducting clinical research in drug development in the pharmaceutical industry. At Rugers, he works with a number of pharmaceutical companies to develop new treatments for hematological malignancies. With the resources available that can only be found at a National Cancer Institute-designated Comprehensive Cancer Center, he is also developing my own investigator initiated clinical study, participating in studies with national academic oncology cooperative groups, and working with a small start-up biotech company spun off from a Rutgers lab, to help them bring their molecule to a first-in-human study. This rich and fertile clinical research environment gives patients access to clinical studies and novel treatments.